Integral Health Asset Management, LLC Ardelyx, Inc. Transaction History

Integral Health Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$1.27 - $8.17 $88,900 - $571,900	-70,000 Closed	0 $0
Q2 2021 Aug 30, 2021	SELL	$6.55 - $8.98 $458,500 - $628,600	-70,000 Reduced 50.0%	70,000 $531,000
Q2 2021 Aug 13, 2021	BUY	$6.55 - $8.98 $294,750 - $404,100	45,000 Added 47.37%	140,000 $1.06 Million
Q1 2021 May 10, 2021	BUY	$6.1 - $7.69 $579,500 - $730,550	95,000 New	95,000 $629,000

244

161M

697K

1.61M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $908M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.